Pretreatment of RPE Cells with Lutein Can Mitigate Bevacizumab-Induced Increases in Angiogenin and bFGF

Publisher: Karger

E-ISSN: 1423-0259|57|1|48-53

ISSN: 0030-3747

Source: Ophthalmic Research, Vol.57, Iss.1, 2016-10, pp. : 48-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content